


Crucible Therapeutics Email Formats
Biotechnology Research • • 1-10 Employees
Crucible Therapeutics Email Formats
Crucible Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@crucible-tx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@crucible-tx.com | 100% |
Key Contacts at Crucible Therapeutics
Jonathan Foley
Director
Cliff Holloway
Chief Executive Officer
Neill Moray Mackenzie
Founding Board Member And Chief Executive Officer
Guillaume Hautbergue
Chief Scientific Officer, Co-Founder & Director
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
About Crucible Therapeutics
Crucible brings together a highly collaborative team of R&D experts and biotech entrepreneurs. With deep expertise across research, development, and commercialization, we are dedicated to advancing innovative RNA-based therapies to transform patient outcomes. Our breakthrough treatment programmes aim to halt degenerative conditions such as Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Crucible is developing novel therapies that prevent rogue nuclear RNAs from escaping into the cytoplasm where they drive toxic gain-of-functions and cell damage. Our approach disrupts the production of toxic dipeptide repeats (DPRs) and TDP-43 aggregates, which are relevant to both C9ORF72- and Sporadic-ALS populations and potentially other neurodegenerative diseases. Crucible Therapeutics was founded in 2023 to advance ground breaking innovations in neuroscience, originating from the Sheffield Institute for Translational Neuroscience (SITraN) and the Division of Neuroscience at the University of Sheffield, UK.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Crucible Therapeutics has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
Crucible Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



